Birndt, S., Hammersen, J., Döhner, K., Reuken, P., Sauerbrey, P., Rosée, F. L., . . . Hochhaus, A. (2023). P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERINFLAMMATION: THE RUXCOFLAM TRIAL. Wiley.
Chicago Style (17th ed.) CitationBirndt, Sebastian, et al. P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERINFLAMMATION: THE RUXCOFLAM TRIAL. Wiley, 2023.
MLA (9th ed.) CitationBirndt, Sebastian, et al. P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERINFLAMMATION: THE RUXCOFLAM TRIAL. Wiley, 2023.
Warning: These citations may not always be 100% accurate.